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Implication for health policy/practice/research/medical education:
The present study findings showed that Urtica dioica extract could decrease the morphine withdrawal signs and might be 
beneficial in addicted patients.
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Introduction: Previous studies have shown the analgesic, anticonvulsant, spasmolytic, 
and anti-inflammatory effects of Urtica dioica (UD). In the present study the effects of 
hydroalcoholic extract of UD on morphine withdrawal signs were investigated. Acute toxicity 
(LD50) of the extract was also assessed.
Methods: In an experimental study, 48 male NMRI mice were randomly divided into 6 groups 
of 8 each, consisting of control (10 mL/kg), clonidine (3.5 mg/kg), and different doses of UD 
extract (25, 50,100 and 200 mg/kg). Morphine dependency was induced by administration 
of different doses of morphine (50, 50, 75, and 50 mg/kg) within a four-day schedule (1st-4th 
day, respectively). On the last day, after administration of a single dose of morphine, naloxone 
(5 mg/kg) was injected and the withdrawal signs were recorded within 30 minutes. To assess 
acute toxicity (LD50), 12 extra rats were used and toxic effects of different doses of the extract 
were evaluated by Lorke’s method.
Results: All doses of the UD extract, compared to control group, significantly decreased the 
number of jumping, grooming, teeth chattering, rearing, wet dog shakes, diarrhea, writing 
and climbing. In addition, the LD50 of the extract was 2.9 g/kg.
Conclusion: UD extract could decrease the morphine withdrawal signs and might be 
beneficial in addicted patients. However, further studies are needed to clarify the exact 
mechanism of its action.
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Introduction
Physical dependence is one of the unwanted and long-
term effects of opioid use (including morphine) that is 
characterized by signs of morphine withdrawal. These 
signs are characterized by various hateful behaviors and 
a number of physiological signs in many species. The 
withdrawal syndrome is clearly present particularly after 
cessation of morphine use or after the administration of 
opioid antagonists in addicted subjects (1,2). 
Previous studies have suggested that various systems, 
including dopaminergic, noradrenergic, and GABAergic 
systems are involved in the process of development of these 
signs. However, studies on the impact of other effective 
systems on the development of morphine withdrawal 
signs are still ongoing (3-8). 
Currently, various chemical drugs such as methadone are 
routinely used to control and treat some of the symptoms 
in opioid addicts. However, many patients do not respond 
to this method and even experience some side effects 
(9,10). Accordingly, the use of drugs with low-side effects, 
especially herbal drugs, is one of the research priorities 
across the globe. The beneficial effects of certain plants 
such as Carthamus tinctorius L., Rosa damascena, Avena 
sativa L., Ferula gummosa Boiss, Salvia leriifolia, Passiflora 
incarnata L., Origanum majorana L., and Pimpinella 
anisum to reduce the morphine withdrawal signs have 
previously been demonstrated (11-19).
Urtica dioica (UD) is an herbaceous, perennial plant 
with an erect stem. reaching a height of up to one 
meter. This plant has a creeping root that is constantly 
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growing. Studies have shown that flavonoids such as 
quercetin and kaempferol exist in the UD structure. This 
plant also contains vitamins C and K, and B vitamins. 
Previous studies have shown analgesic, anticonvulsant, 
antispasmodic, sexual enhancer, and anti-inflammatory 
effects of UD (20). Considering this background and 
the lack of a study in this regard, this study was first to 
investigate the effect of hydroalcoholic UD extract on the 
morphine withdrawal signs in male mice. Acute toxicity 
(LD50) of the extract was also assessed.
Materials and Methods
Animals
In this experimental study, a total 60 (48 mice for morphine 
dependence study and 12 mice for acute toxicity study) 
male NMRI mice (obtained from the Animal House of 
Urmia University of Medical Sciences, Iran) weighing 
20-30 g were used. Animals were kept in separate cages at 
23 ± 2°C and a 12-hour light/12-hour dark cycle. During 
this period, commercially available water and food (in the 
form of a commercial pellet) were provided to them, and 
each animal was used only once. All experiments were 
carried out during the light period from 8:00 to 12:00. 
Drugs and extracts
In the present study, morphine sulfate (Temad Co., Iran), 
naloxone hydrochloride (Tolidaru, Iran) and clonidine 
hydrochloride (Tolidaru, Iran) were used. The extract of 
UD was purchased from Giah Essence Pharmaceutical 
Co., (Gorgan, Iran, Bath no.: 005). In this study, all drugs 
and even the extract were administered intraperitoneally 
at constant volume of 10 mL/kg. All drugs were dissolved 
in normal saline (0.9%).
Morphine dependence
Morphine was injected for four consecutive days as follows: 
From the first to third day, the mice were administered 
with, respectively, 50, 50, and 75 mg/kg doses of morphine 
according to a regular program at 8:00, 11:00, and 15:00, 
daily. On day 4, mice received only a single dose (50 mg/
kg) of morphine at 8:00, and 2 hours later, naloxone at 5 
mg/kg was injected (11,17,19).
Animals were completely randomly assigned to 6 groups 
of 8 each, as follows: 1) Negative control group: The mice 
in this group received normal saline (10 mg/kg, i.p.) 30 
minutes prior to receiving the last dose of morphine (50 
mg/kg) on the fourth day and 30 minutes later, received 
naloxone (5 mg/kg), and then the signs were recorded.
2) Standard drug (clonidine) group: The mice in this 
group received clonidine (3.5 mg/kg, i.p.) 30 minutes 
prior to receiving the last dose of morphine (50 mg/kg) on 
the fourth day and 30 minutes later, received naloxone (5 
mg/kg), and then the signs were recorded.
3) Groups treated with different doses of hydroalcoholic 
extract of UD: The mice in these groups received UD 
extract at different doses (25, 50, 100, and 200 mg/kg) 30 
minutes prior to receiving the last dose of morphine (50 
mg/kg) on the fourth day and 30 minutes later, received 
naloxone (5 mg/kg), and then the signs were recorded 
(11,17,19). In this study, the administration schedule of 
the drugs and extracts and the doses were selected with 
reference to the previous studies (11,17,19,21).
After injection of the extract or drugs, the mice were 
quickly transferred into a cylindrical glass 25 cm in 
diameter and 40 cm in height. The morphine withdrawal 
signs including the number of jumping, behaviors such 
as grooming, climbing, rearing, teeth chattering, wet 
dog shakes, diarrhea, and writing were recorded for 30 
minutes (17,19). In this study, all signs were recorded by a 
single person who was blind to the grouping of the mice.
Acute toxicity test (LD50)
We used the Lorke’s method to determine the extract acute 
toxicity (LD50) (21). This method consists of two separate 
phases. In the first phase, nine animals in three groups of 
three each received different doses of UD extract (10, 100 
and 1000 mg/kg, i.p.). The animals were monitored for 
any signs of toxicity and possible death during 24 hours. 
In the second phase, 3 animals in each group received 
different higher doses (1600, 2900 and 5000 mg/kg, i.p.) 
of UD extract. Similar to the first phase, the mice were 
monitored for any signs of toxicity and possible deaths 
during 24 hours. After the two phases, the LD50 was 
calculated by the following formula:
LD50 = 0 100D D×
Where:
D0 = Highest dose in which no mortality occurred, 
D100 = Lowest dose that caused mortality (22).
Statistical analysis 
In this study, quantitative data (number of jumps) were 
expressed as mean ± standard error of mean (SEM) and 
qualitative data (grooming, teeth chattering, writing, 
diarrhea, climbing, rearing, and wet dog shakes) as 
25%-median-75%. For analysis of quantitative data, one-
way analysis of variance (ANOVA) and then Tukey’s test 
were used, and for analysis of the qualitative data, the 
Mann-Whitney U test was used. P < 0.05 was considered 
significance level. The SPSS version 19 was used to analyze 
the data.
Results
The effects of different doses of extract on morphine 
withdrawal signs
All doses of UD extract reduced the number of jumping 
(P < 0.001) when compared to control group in 
morphine-dependent mice (Figure 1). All 3 doses of the 
extract reduced grooming, teeth chattering, rearing, wet 
dog shakes, and diarrhea. But, all doses of the extract 
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decreased the writing and climbing behaviors (P < 0.05). 
In addition, clonidine as a reference drug reduced the 
number of jumping (P < 0.001), grooming (P < 0.01), 
teeth chattering (P < 0.05), climbing (P < 0.05), writhing 
(P < 0.01) and diarrhea (P < 0.01). But, clonidine could not 
reduce the rearing and wet dog shake behaviors (P > 0.05).
Acute toxicity test
No mortality was observed in any doses of extract except 
for the highest dose (5000mg/kg). On the other hand, 
based on our findings the LD50 of UD extract was 2.9 g/kg. 
Hence, the administration of any doses less than 2900 mg/
kg was safe in mice. Furthermore, some signs of toxicity 
including numbness, diarrhea and ataxia were observed 
with 2900 mg/kg of the extract in mice (Table 1).
Discussion 
In this study, the effect of hydroalcoholic extract of UD on 
the morphine withdrawal signs in morphine-dependent 
mice was investigated. Consistent with the previous studies 
(17,19), the 3-day morphine administration caused a 
physical dependence and, following the administration of 
naloxone, morphine withdrawal signs were observed. The 
results showed that pretreatment with different doses of 
UD extract reduced the number of jumping in morphine-
dependent mice. However, all four doses of UD extract 
significantly decreased the number of jumping more 
markedly than the standard drug clonidine (one of the 
α2 adrenergic drugs). As a standard drug; clonidine also 
decreased the number of jumping in morphine dependent 
mice. Clonidine is used to reduce the morphine withdrawal 
signs in humans and animals (23). These results are in 
agreement with the results of other studies (24,25). 
The number of jumping is one of the most important signs 
to determination the severity of morphine withdrawal 
signs (2). Previous studies have reported that serotonergic, 
cholinergic, and GABAergic systems are involved in the 
number of jumping caused by morphine withdrawal 
syndrome (3-8). In this regard, it has been shown that 
the serotonergic and cholinergic systems increase the 
number of jumping and the GABAergic system reduces 
the number of jumping in morphine dependent mice (26). 
In this regard, in agreement with our findings, previous 
studies have also highlighted the number of jumping 
(the most important symptom of morphine withdrawal) 
as an important behavior to study morphine tolerance 
or dependence. In other words, various extracts or 
essential oils reduce the number of jumping in morphine-
dependent mice (9-17).
Among other important morphine withdrawal signs, 
diarrhea can be mentioned. According to previous 
studies, the cholinergic system is involved in development 
of diarrhea (27). The results showed that all three doses of 
the extract and clonidine reduced diarrhea in morphine 
dependent mice. In addition to diarrhea, other signs, such 
as grooming, teeth chattering, rearing, wet dog shakes, 
writing, and climbing were reduced by the extract. 
Considering the findings of this study, the strengths 
point of the study include the determination of the effect 
of hydroalcoholic UD extract in reducing the signs of 
morphine withdrawal syndrome and a limitation of the 
















r   o 




s   
/   

























Figure 1. Effect of different doses of hydroalcoholic extract of Urtica 
dioica (UD) and clonidine on the number of naloxone-induced jumping 
in morphine dependent mice. The results were expressed as mean ± 
standard error of measurement for eight mice.*** P < 0.001 compared 
to control group. CTR: Control; CLON: Clonidine.
Table 1. Effect of different doses of hydroalcoholic extract of Urtica dioica (UD) on morphine withdrawal signs
Parameter/Group Grooming Teeth 
chattering
Climbing Rearing Wet dog shakes Writing Diarrhea
Negative control (normal saline), 10 mL/kg (3-2)± 2.5 (3-1)±2 (3-1)±2 (3-1)±2.5 (2-1)±1.5 (3- 2)±2 (3-2)±2.5
Positive control (clonidine), 3.5 mg/kg (1-0)±1** (1-0)±1* (1-1)±1* (1-1)± 1 (1-1)±1 (0- 0)±0** (1-0)±0.5**
UD 25 mg/kg (2-1)±2 (3- 1)± 1 (1-0)± 1* (1-1)± 1 (1-1)±1 (0-0)±0** (3-1)±3
UD 50 mg/kg (2- 1)±1* (1-1)±1* (1-1)±1* (1-1)±1* (1-0)±0* (1-0)±0** (2-0)±1*
UD 100 mg/kg (2-1)±1* (1-0)±1* (1-0)±1* (1-1)±1* (1-0)±0* (00-0)±0** (1-0)±1**
UD 200 mg/kg (1-0)±1** (1-0)±1* (1-0)±1* (1-1)±1* ((0-0)±0* (00-0)±0** (1-0)±0**
In this study, qualitative data were expressed as 25%-median-75%, and for data analysis, Mann-Whitney U test was used.  
*P < 0.05; **P < 0.01, compared to control group. CTR: Control; CLON: Clonidine.
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Therefore, the UD components are responsible for 
its effects on reduction in the morphine withdrawal 
signs. In this regard, the phytochemical investigations 
have shown that in this plant there are numerous 
components such as fatty acids (e.g., α-linolenic acid), 
carotenoids (e.g., lutein isomers, beta-carotene isomers, 
and lycopene isomers), phenols (e.g., ferulic acid, gallic 
acid, and synergic acid), flavonoids (e.g., catechin and 
epicatechin) and other components including neoxetine 
and violaxanthin (26). However, studies have suggested 
that phenolic and flavonoid components in plants, by 
inhibiting the cholinergic system, may lead to inhibition 
of cholinesterase activity and subsequently reduction 
in the signs of morphine withdrawal syndrome (27). 
Meanwhile, ursolic acid and quercetin are two of the most 
important components of UD extract (28). In a similar 
study, Naidu et al. reported that quercetin induced the 
relapse of morphine tolerance and dependence. Quercetin 
causes reduction in the frequency of naloxone-induced 
jumping in morphine dependent mice (29). In addition, 
studies have reported that quercetin may reduce the 
naloxone-induced abdominal contractions through 
the mechanism of inhibiting the activity of nitric oxide 
synthase (30). In a similar study, flavonoids in plants 
(including quercetin) have reduced some of the morphine 
withdrawal signs, including abdominal contractions, 
diarrhea, teeth, number of jumps. This links the effects 
of flavonoids to their effects on the GABAergic system 
(31,32). In addition to the quercetin, ursolic acid has 
shown different pharmacological effects in rodents 
including neuroprotective, antidepressant-like effect, 
antinociceptive and anxiolytic effects (33-35). On the 
other hand, Taviano et al demonstrated that ursolic acid 
isolated from Nepta sibthorpii inhibited the acetic acid-
induced abdominal constriction. They also observed 
that naloxone could reverse the antinociceptive effects of 
ursolic acid in hot plate test. Hence, the antinociceptive 
effects of ursolic acid partly mediated by modulation of 
opioidergic system (36). Therefore, it may be opioidergic 
system that is involved in the alleviating effects of UD on 
morphine withdrawal signs.
Besides that, acute toxicity test demonstrated that the LD50 
of UD extract was 2.9 g/kg. Hence, the administration of 
any doses less than 2900 mg/kg was safe in mice. On the 
other hand, the LD50 of 5000 mg/kg or higher in animal’s 
should be considered to be practically harmless.
However, the use of various antagonists and the study 
of the effect of each of the active ingredients of UD on 
morphine withdrawal signs are suggested to determine 
the exact mechanism action of the hydroalcoholic extract 
of UD.
Conclusion
In conclusion, our results firstly demonstrate that the 
Urtica dioica extract could decrease the morphine 
withdrawal signs and might be beneficial in addicted 
patients. However, further studies are needed to clarify the 
exact mechanism of its action.
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